Cresco Labs (CRLBF) Notes Payables (2020 - 2025)

Cresco Labs has reported Notes Payables for 6 years, with the latest figure at $10.8 million in Q4 2025.

• For the quarter ending Q4 2025, Notes Payables changed N/A year-over-year to $10.8 million; the trailing twelve-month figure through Dec 2025 stood at $10.8 million (changed N/A YoY), and the FY2025 full-year result was $10.8 million, changed N/A from the prior year.
• Notes Payables for Q4 2025 stood at $10.8 million, down from $22.3 million in the prior quarter.
• The five-year high for Notes Payables was $29.2 million in Q1 2022, with the low at $10.8 million in Q4 2025.
• Historically, Notes Payables has averaged $20.5 million across 5 years, with a median of $21.7 million in 2024.
• The largest YoY upside for Notes Payables was 4.24% in 2022 against a maximum downside of 4.24% in 2022.
• Cresco Labs' Notes Payables stood at $28.0 million in 2021, then grew by 2.97% to $28.8 million in 2022, then sank by 59.04% to $11.8 million in 2023, then soared by 88.33% to $22.3 million in 2024, then tumbled by 51.54% to $10.8 million in 2025.
• The last three Notes Payables figures came in at $10.8 million (Q4 2025), $22.3 million (Q3 2024), and $12.3 million (Q2 2024), per Business Quant data.